Quantcast

Latest Diabetic retinopathy Stories

2011-02-15 08:20:43

(Ivanhoe Newswire) -- Grab some walnuts and a plate of fish, new research shows Omega-3 fatty acids found in these foods may keep you seeing straight. Past research has shown that Omega 3's may help prevent human blindness, but a new study in mice reveals exactly how that works. Omega-3 fatty acids are fats commonly found in fish oil.  Several years ago researchers at Children's Hospital Boston determined that the fatty acids helped to prevent retinopathy, which is a major form of...

2011-02-10 00:27:28

Study reveals how they work in preventing several forms of blindness Omega-3 fatty acids "“fats commonly found in fish oil "“ were shown several years ago to prevent retinopathy, a major form of blindness, in a mouse model of the disease. A follow-up study, from the same research team at Children's Hospital Boston, now reveals exactly how omega-3's provide protection, and provides reassurance that widely used COX-inhibiting drugs like aspirin and NSAIDs don't negate their benefit....

2011-02-09 08:00:00

TARRYTOWN, N.Y., Feb. 9, 2011 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today announced that it will webcast an investor briefing on Sunday, February 13 from 9 a.m. to 10:30 a.m. Eastern Time. At the investor briefing, principal investigators from the VEGF Trap-Eye clinical studies will recap presentations from the Bascom Palmer Eye Institute's Angiogenesis, Exudation and Degeneration 2011 meeting being held in Miami, Florida on Saturday, February 12. The...

2011-01-13 15:19:43

The inhibition or removal of an enzyme may prevent or treat ischemic retinopathy by stalling growth of unwanted vessels in the retina, Medical College of Georgia researchers say. Ischemic retinopathy is characterized by uncontrolled formation of new blood vessels in the retina, and is seen in diseases such as diabetic retinopathy and retinopathy of prematurity. While this blood vessel formation, called neovascularization, can benefit ischemic heart disease and wound healing, it is bad in the...

2011-01-10 06:00:00

PLAINVIEW, N.Y., Jan. 10, 2011 /PRNewswire/ -- Just in time for the new year, Davis Vision announces the launch of its new health and wellness program, the Eye Health Connection Program. With expanded coverage for eye exams and eyewear, it will offer cost savings, greater flexibility and enhanced benefits to members. Focusing on the four leading eye conditions - age-related macular degeneration, glaucoma, cataracts and diabetic retinopathy, Davis Vision's new program elevates benefits and...

2010-12-20 05:00:00

TARRYTOWN, N.Y. and BERLIN, Dec. 20, 2010 /PRNewswire-FirstCall/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) and Bayer HealthCare today announced positive top-line results for VEGF Trap-Eye (aflibercept ophthalmic solution) in the COPERNICUS study, which is led by Regeneron, the first of two Phase 3 studies in patients with macular edema due to central retinal vein occlusion (CRVO). In this trial, 56.1 percent of patients receiving VEGF Trap-Eye 2 milligrams (mg) monthly gained at...

2010-12-20 00:10:00

TARRYTOWN, N.Y., Dec. 20, 2010 /PRNewswire-FirstCall/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today announced that it will hold a teleconference and webcast at 8:30 a.m. Eastern Time on Monday, December 20, to discuss results of the Phase 3 COPERNICUS study with VEGF Trap-Eye in central retinal vein occlusion (CRVO) and the week 52 follow-up results of the Phase 2 DA VINCI study in patients with diabetic macular edema (DME). A press release will be issued prior to the call....

2010-12-09 15:28:00

A Statement from JDRF President and CEO, Jeffrey Brewer NEW YORK, Dec. 9, 2010 /PRNewswire-USNewswire/ -- "Today Congress passed a multi-year renewal of the Special Diabetes Program (SDP), ensuring that studies on promising diabetes treatments and avenues toward a cure continue uninterrupted. As the father of a son living with type 1 diabetes, and as CEO of JDRF, one of the leading advocates for the renewal of this program, I applaud the U.S. government for its continued commitment to end...

2010-11-21 23:00:00

TARRYTOWN, N.Y. and BERLIN, Nov. 22, 2010 /PRNewswire-FirstCall/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) and Bayer HealthCare today announced that in two parallel Phase 3 studies in patients with the neovascular form of age-related macular degeneration (wet AMD), all regimens of VEGF Trap-Eye (aflibercept ophthalmic solution), including VEGF Trap-Eye dosed every two months, successfully met the primary endpoint compared to the current standard of care, ranibizumab dosed every...

2010-11-09 11:12:03

One drug's startling ability to restore retinal health in the eyes of diabetic mice has researchers wanting to learn more about how it works and whether it might do the same for people. "We want to know if this drug has the potential to block the visual devastation that can occur with diabetes," said Dr. Sylvia Smith, retinal cell biologist and co-director of the Vision Discovery Institute at the Medical College of Georgia. "That means we need to know more about how and when it is...


Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.